Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

recombinant interferon alfa

DRUG

tretinoin liposome

Trial Locations (2)

10021

New York Weill Cornell Cancer Center at Cornell University, New York

10032

Herbert Irving Comprehensive Cancer Center at Columbia University, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT00003656 - Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter